Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
chinadiplomacy.org.cn's Diplomacy Talk | China's proposals contribute to global development 2022-03-14 21:00
Tims China Confirms Financing Commitment 2022-03-14 21:00
MediLink Therapeutics closes US$70 million Series B financing 2022-03-14 20:50
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics 2022-03-14 20:30
MingZhu Logistics Enters into Share Purchase Agreement to Acquire Yinhua (BVI) Limited 2022-03-14 20:00
Yum China Provides Update on the First Quarter 2022 Business Performance Amid the Latest COVID-19 Development in China 2022-03-14 20:00
Farmmi Wins Repeat Customer Order Exporting to Vancouver 2022-03-14 20:00
111, Inc. Becomes First Online Retail Platform for BGI's SARS-CoV-2 Virus Antigen Detection Kits 2022-03-14 19:35
Cloud Village Inc. to Report Fiscal Year 2021 Financial Results on March 24 2022-03-14 19:30
Glory Star Announces Receipt of Non-Binding Going Private Proposal 2022-03-14 19:00
Boqii Announces Senior Management Change 2022-03-14 19:00
JinkoSolar Receives UNGC Best Practices Sustainable Award 2021 2022-03-14 18:57
CHINA Season 2: A Retrospective of International Friends in Chinese History, Unfolding Chinese Stories in a Historical and Cultural Documentary 2022-03-14 18:39
Zhihu Inc. Reports Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results 2022-03-14 18:00
Viomi Technology Co., Ltd to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, March 28, 2022 2022-03-14 17:00
Hexvix® Has Obtained CDE Approval for the Inclusion In the Clinical Real-world Evidence Pilot Study 2022-03-14 14:25
Impact Therapeutics Announces Completion of Series D1 Financing 2022-03-14 12:43
ZIM to Launch ZIM eCommerce Baltimore eXpress (ZXB), a New Speedy eCommerce service from China and South-East Asia to the US East Coast 2022-03-14 10:00
InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Waldenström's Macroglobulinemia in China 2022-03-14 08:30
CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer 2022-03-14 08:05
1 1309 1310 1311 1312 1313 3796